GFC:EURONEXT PARISGecina SA Analysis

Genesis Fertility Center trades at a price well below its discounted cash‑flow estimate, with the DCF model suggesting a fair value around 2.9 THB versus the current 2.26 THB. The stock’s 20‑day SMA sits beneath the 50‑day and 200‑day averages, confirming a bearish price trend, yet the RSI of roughly 35 signals oversold conditions and the MACD line has just crossed above its signal, hinting at a possible short‑term rebound. Valuation metrics reinforce the cheapness: the trailing P/E of 22.6 is under the industry average of 30, and the price‑to‑book is below 1.0, while the dividend yield is an attractive 5.75 % but the payout ratio exceeds 100 %, raising sustainability concerns. Financially, the company carries modest debt, a solid cash position, and a positive free cash flow, but revenue is contracting sharply and operating margins are negative, limiting growth prospects.
Volatility is moderate (≈18 % over 30 days) and beta is near zero, indicating limited market‑wide sensitivity, yet the max drawdown of over 45 % reflects historical price weakness. Overall, the combination of deep valuation discount, strong cash generation, and technical oversold signals supports a cautious upside view, tempered by declining top‑line performance and regulatory exposure in the fertility sector.